| About the author: |
A. Y. Mammadzada, Sh. G. Ismayilova |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The purpose of the study was to study the relationship between lipid metabolism and flow-mediated dilation and endothelium-independent vascular dilation in diabetic nephropathy patients. The study included 120 patients with chronic kidney disease against the background of diabetic nephropathy. They were divided into 4 groups according to the stages of disease. The level of flow-mediated dilation in the brachial artery was determined by the hyperemic test and the level of endothelium-independent vascular dilation by the nitroglycerin test. The lipid spectrum was assessed by the level of total cholesterol, triglycerides, high-density lipoproteins, low-density lipoproteins in blood serum, as well as by calculating the atherogenic coefficient. In the 1st group, a moderate inverse relationship was determined between flow-mediated dilation and total cholesterol, triglycerides, atherogenic coefficient (respectively, r=–0.503, p<0.05; r=–0.513, p<0 0.05; r=–0.531, p<0.05). At subsequent stages of chronic kidney disease, the correlation in the groups was of the same nature (0.726, p<0.01). Thus, the results obtained indicate the effect of changes in the blood lipid spectrum on the degree of flow-mediated dilation and absence of influence on endothelium-independent vascular dilation. |
| Tags |
diabetic nephropathy,flow-mediated dilation,nitroglycerine-induced vasodilation,lipid metabolism |
| Bibliography |
- Agayev M, Mammadova I, Ismayilova Sh, SP315. Influence of lipid metabolism disorders on endothelial function in chronic kidney disease, Nephrology Dialysis Transplantation, 2015; 30(3):483, https://doi.org/10.1093/ndt/gfv191.35
- Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045. doi: 10.2215/CJN.11491116.
- Bianchi S, Baronti A, Cominotto R, Bigazzi R. Le alterazioni del metabolismo lipidico nella malattia renale cronica [Lipid metabolism abnormalities in Chronic Kidney Disease]. G Ital Nefrol. 2016 Malattie Metaboliche e Rene;33(S68):gin/33.S68.2. [In Italian].
- Ito H, Nakashima M, Meguro K, Furukawa H, Yamashita H, Takaki A, et al. Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease. J Diabetes Res. 2015; 2015:728127. doi: 10.1155/2015/728127.
- Katerenchuk IP, Rustamian ST. Assessment of adhesion to treatment of patients being on kidney replacement therapy taking into account the presence of type 2 diabetes mellitus. World of medicine and biology. 2021; 3 (77): 73–77.
- Kobayashi, S. Cardiovascular events in chronic kidney disease (CKD) – an importance of vascular calcification and microcirculatory impairment. Ren Replace Ther. 2016; 2: 55. https://doi.org/10.1186/s41100-016-0062-y
- Miao C, Zhu X, Wei X, Long M, Jiang L, Li C, Jin D, Du Y. Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases. Ren Fail. 2022 Dec;44(1):881–892. doi: 10.1080/0886022X.2022.2079528.
- Mikolasevic I, Žutelija M, Mavrinac V, Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis. 2017 Feb 7;10:35–45. doi: 10.2147/IJNRD.S101808.
- Nazar CM. Diabetic nephropathy; principles of diagnosis and treatment of diabetic kidney disease. J Nephropharmacol. 2014 Jan 1;3(1):15–20.
- Opazo-Ríos L, Mas S, Marín-Royo G, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. Int J Mol Sci. 2020 Apr 10;21(7):2632. doi: 10.3390/ijms21072632.
- Pontremoli R, Bellizzi V, Bianchi S, Bigazzi R, Cernaro V, Del Vecchio L, et al. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology. J Nephrol. 2020 Jun;33(3):417–430. doi: 10.1007/s40620-020-00707-2.
- Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI.Clinical predictive factors in diabetic kidney disease progression. Journal of diabetes investigation, 2017); 8(1): 6–18. https://doi.org/10.1111/jdi.12533
- Reutens AT. Epidemiology of diabetic kidney disease. The Medical clinics of North America. 2013: 97(1): 1–18. https://doi.org/10.1016/j.mcna.2012.10.001
|
| Publication of the article |
«World of Medicine and Biology» №1(83), 2023 year, 126-130 pages, index UDK 616.61-004.6 |
| DOI |
10.26724/2079-8334-2023-1-83-126-130 |
